Search

Search Constraints

You searched for: Author/Creator Leoni, Mollie

Search Results

1. Long‐term disease control and safety with the anti‐CCR4 antibody mogamulizumab: Post‐hoc analyses from the MAVORIC trial of patients with previously treated cutaneous T‐cell lymphoma. Issue 8 (28th June 2022)

2. Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial. Issue 9 (September 2018)

3. Quality of life in cutaneous T cell lymphoma patients treated with the anti-CCR4 monoclonal antibody mogamulizumab versus vorinostat: Results from MAVORIC. (September 2018)

4. Tipifarnib in Head and Neck Squamous Cell Carcinoma With HRAS Mutations. Issue 17 (10th June 2021)